Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the ΔF508 CFTR mutation

Archives of Dermatology

Volumn 141, Issue 5, 2005, Pages 621-624

  Katz, Kenneth A ^a   Yan, Albert C ^b   Turner, Maria L ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM CHLORIDE; AMIKACIN; BETA CAROTENE; COLECALCIFEROL; CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; IBUPROFEN; MEROPENEM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHYTOMENADIONE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRIACYLGLYCEROL LIPASE; VITAMIN K GROUP;

ADOLESCENT; AQUAGENIC WRINKLING OF THE PALM; ARTICLE; BURNING SENSATION; CASE REPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; EDEMA; FEMALE; GENE IDENTIFICATION; GENE MUTATION; HEADACHE; HOMOZYGOTE; HUMAN; KERATOLYSIS; LUNG INFECTION; MALE; MARASMUS; MYCOBACTERIUM ABSCESSUS; PALMAR DERMATOGLYPHICS; PATHOGENESIS; PRIORITY JOURNAL; PRURITUS; REMISSION; SKIN MANIFESTATION; WATER IMMERSION; WRINKLE;

ADOLESCENT; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HOMOZYGOTE; HUMANS; IMMERSION; MALE; MUTATION; PAIN; SKIN; SKIN AGING; WATER;

EID: 18544379064     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.5.621     Document Type: Article

References (25)

1. Elliott RB. Wrinkling of skin in cystic fibrosis [letter]. Lancet. 1974;2:108.
2. Yan AC, Aasi SZ, Alms WJ, et al. Aquagenic palmoplantar keratoderma. J Am Acad Dermatol. 2001;44:696-899.
3. Itin PH, Lautenschlager S. Aquagenic syringeal acrokeratoderma (transient reactive papulotranslucent acrokeratoderma). Dermatology. 2002;204:8-11.
4. Sweeney SM, Wiss K, Kuchnir L. Inhibition of aquagenic syringeal acrokeratoderma with hypertonic saline. Abstract presented at: Society of Pediatric Dermatology 2002 Annual Meeting; July 17-20, 2002; Annapolis, Md.
5. Lowes MA, Khaira GS, Holt D. Transient reactive papulotranslucent acrokeratoderma associated with cystic fibrosis. Australas J Dermatol. 2000;41:172-174.
6. MacCormack MA, Wiss K, Malhotra R. Aquagenic syringeal acrokeratoderma: report of two teenage cases. J Am Acad Dermatol. 2001;45:124-126.
7. Kulczycki LL, Kostuch M, Bellanti JA. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFR mutations to genotype-phenotype manifestations. Am J Med Genet A. 2003;116:262-267.
8. NOAA/National Climatic Data Center. Local Climatological Data: Seattle, WA-June-August 2003. Asheville, NC: National Climatic Data Center; 2003.
9. Norman AP, Mall ML, Johns MK. Skin wrinkling in cystic fibrosis [letter]. Lancet. 1974;2:358-359.
10. Elliott RB. Skin wrinkling in cystic fibrosis [letter]. Lancet. 1974;2:1383.
11. Betlloch I, Vergara G, Albares MP, Pascual JC, Silvestre J-F, Botella R. Aquagenic keratoderma. J Eur Acad Dermatol Venereol. 2003;17:306-307.
12. English JC, McCollough ML. Transient reactive papulotranslucent acrokeratoderma. J Am Acad Dermatol. 1996;34:686-687.
13. Carder KR, Weston WL. Rofecoxib-induced instant aquagenic wrinkling of the palms. Pediatr Dermatol. 2002;19:353-355.
14. Epstein E. Soggy stratum corneum [case report]. Contact Dermatitis. 1983;9:229.
15. Schmults C, Sidhu G, Urbanek RW. Aquagenic syringeal acrokeratoderma [case report]. Dermatol Online J. 2003;9:27.
16. Onwukwe MF, Mihm MC, Toda K. Hereditary papulotranslucent acrokeratoderma: a new variant of familial punctate keratoderma? Arch Dermatol. 1973;108:108-110.
17. Johns MK. Skin wrinkling in cystic fibrosis. Med Biol Illus. 1975;25:205-210.
18. Moynahan EJ. Skin wrinkling in cystic fibrosis [letter]. Lancet. 1974;2:907.
19. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
20. De Braekeleer M, Allard C, Leblanc JP, Aubin G, Simard F. Correlation of sweat chloride concentration with genotypes in cystic fibrosis patients in Saguenay Lac-Saint-Jean, Quebec, Canada. Clin Biochem. 1998;31:33-36.
21. Mickle JE, Macek M Jr, Fulmer-Smentek SB, et al. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet. 1998;7:729-735.
22. Yigit H, Selimoglu MA, Altinkaynak S. Sweat test results in children with primary protein energy malnutrition. J Pediatr Gastroenterol Nutr. 2003;37:242-245.
23. Schwartz JI, Vandormael K, Malice MP, et al. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther. 2002;72:50-61.
24. Schreiber R, Nitschke R, Greger R, Kunzelmann K. The cystic fibrosis transmembrane conductance regulator activates aquaporin 3 in airway epithelial cells. J Biol Chem. 1999;274:11811-11816.
25. Agren J, Zelenin S, Hakansson M, et al. Transepidermal water loss in developing rats: role of aquaporins in the immature skin. Pediatr Res. 2003;53:558-565.